I am not an MD, so I am not privy to what today's MDs (esp. oncologists) think about how effective OMICS profiling (transcriptomic, proteomic, metabolomic, lipidomic, glycomic profiling, etc.) is in the early detection of cancer. Perhaps it depends on the type of cancer? If so, which types? If you're an MD, I would appreciate your opinion.
I am a practicing oncologist in a "third world" country so that my opinion is biassed.
OMICS are very important to establish a therapeutic and pronostic schedule for cancer patients, but due to its very high cost, we can only afford it in very few and specific cases. Of course, MDs working in "rich countries" may have a different view on this issue.
At the research level, OMICS are part of the usual experiments, in rich and not so rich countries.
The future of oncology will necessarily include OMICS as part of the diagnostic workup of a cancer patient.
- Badges
- Science topic
- Similar topics
- Social Science
- Sociology